Source: International Congress 2014 – Animal models in respiratory drug development
Disease area: Airway diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
D. Zajac, A. Stasinska, M. Pokorski (Warsaw, Poland). Lipid derivatives of dopamine and respiration. Eur Respir J 2014; 44: Suppl. 58, 1796

Member's Comments

No comment yet.

Related content which might interest you: Dopamine metabolism and the ventilatory response to hypoxia in the rat Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014 AZD5069: Pharmacological profile of a CXCR2 antagonist in development for the treatment of respiratory disorders Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 In vitro characterization of a novel inhaled PI3Kd inhibitor LAS194223 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Inflammation in COPD patients before and after roflumilast treatment Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Bronchoprotective activity and safety assessment of two novel dual-acting MABA compounds (LAS190792 and LAS191351) in dogs Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 In vitro pharmacological characterization of two novel dual-acting MABA compounds (LAS190792 and LAS191351) Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Inhaler technique – A time to re-educate patients? Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 In vitro profile of the new inhaled pan-JAK inhibitor LAS194046 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstriction Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Therapeutic potential of CPL-407-105 – Novel potent JAK/STAT pathway inhibitor for the treatment of asthma Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Development of a lung slice methodology to study the mechanisms of lung uptake and lysosomal trapping Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Role of IL-1beta in vagal mediated control of respiration Source: International Congress 2014 – Paediatric respiratory physiology in health and disease Year: 2014 Blockade of TSLP pathway alters asthma biomarkers Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 The inverse agonist propranolol does not confer steroid-sparing activity in persistent asthma Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Translational study searching for synergy between glycopyrronium and indacaterol Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Side effects of the leukotriene receptor antagonists in asthmatic children Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Loss of the calcium-sensing receptor (CaSR) decreases slowly-adapting receptor responsiveness to mechanical stretch independent of oxygenation status Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Leukotrienes pathway are involved in the anti-inflammatory effects aerobic exercise on asthma Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014